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INORGANIC NANOWIRES
This application is a Continuation of U.S. application Ser.
No. 13/525,637,filed Jun. 18, 2012, now U.S.Pat. No. 8,523,
044, which is a Continuation of U.S. application Ser. No.
13/041 ,236,filed Mar. 4, 2011, now USS. Pat. No. 8,201,724,
which is a Continuation of U.S. application Ser. No. 10/976,
179,filed Oct. 29, 2004, now U.S. Pat. No. 7,923,109, which
claims benefit under 35 U.S.C. 119(e) to U.S. Provisional
Application No. 60/534,102, filed Jan. 5, 2004, all of which
are hereby incorporated by reference in their entirety.
This invention was made with government support
awarded by the Army Research Office under Grant Number
DAAD19-03-1-0088. The government has certain rights in
the invention.
INTRODUCTION
Thereliance of a wide variety of technologies on develop-
ing scalable and economic methods for the fabrication of
one-dimensional materials, including nanowires and nano-
tubes, has spurred intense and rapid progress in the area of
materials synthesis. For example, one-dimensional materials
have been enthusiastically pursued for their applications in
the study of, for example, electrical transport (1), optical
phenomena (2), and as functional units in nanocircuitry (3).
Pursuit of“bottom up” methodsfor the synthesis of semicon-
ducting, metallic and magnetic nanowires has yielded a vari-
ety of synthetic strategies including, but not limited to, Vapor
Liquid Solid (VLS) (4), chemical (5), solvothermal, vapor
phase, and template-directed fabrication (6). Although each
method developed for the production of nanowires has had
somebasic success in achieving high quality materials, meth-
ods to date have not yielded monodisperse, crystalline
nanowires of radically different compositions. In general,
prior methods for nanowire production can be erratic, syn-
thetically cumbersome, and are not universal. See, for
example, U.S. Pat. No. 6,225,198 to Alivisatoset al. for II-VI
semiconductor production in liquid media and references
cited herein. Reference 4 to Lieberet al. describes the diffi-
culty in finding a universal approach. It describes a VLS
process that requires use of lasers and high temperatures and
produces a nanowire having a nanoparticle at the end which
maynotbe desirable.
Recently, biological factors have been exploited as synthe-
sis directors for nanofibers (7, 8), virus-based particle cages
(9), virus-particle assemblies (10, 11, 12), and non-specific
peptide templates (13). This is due to the high degree of
organization, ease of chemical modification and naturally
occurring self-assembly motifs in these systems.
Belcheret al. have prepared nanowires associated with and
bound to genetically engineered viral scaffolds (see, for
example, U.S. Patent Publication, 2003/0068900 to Belcher
et al.). The scaffolds serve as a template as nanoparticles or
nanocrystals form on the scaffold. Although this technology
is attractive and provides important advantages, a need exists
to improve upon it. For example, it is desirable to generate
improved properties such as improved fusion between the
nanocrystals and reduction in defects. It is also desirable to
fuse the nanocrystals into one long single crystal rod or into
large crystalline domains. Moreover, it is desirable in many
applications to not have and substantially eliminate the viral
scaffold boundto or associated with the viral scaffold. More-
over, it is desirable to control the size and size statistical
distributions for the nanowires including, for example, pre-
pare monodisperse materials and materials having controlled
length. If possible, the nanowires should be usable directly,
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without need for a size-based separation step before use. A
need alsoexists to be able to connect the nanowires with other
components such as electrodes which allow the nanowires to
be commercially useful. These connections should, if pos-
sible, not be mere chance connections but be strategically
directed and controllable.
References numerically cited in this specification are pro-
vided in a listing at the end of the specification and are
incorporated by reference in the specificationin their entirety.
SUMMARY
The present invention in many of its embodiments is sum-
marized in this non-limiting summary section.
In one embodiment, the present invention provides an inor-
ganic nanowire having an organic scaffold substantially
removed from the inorganic nanowire, the inorganic nanow-
ire consisting essentially of fused inorganic nanoparticles
substantially free of the organic scaffold (“the inorganic
nanowire of embodiment1”’).
The present invention also provides compositions and
devices comprising a plurality of these inorganic nanowires.
In another embodiment, the present invention provides a
composition comprising a plurality of inorganic nanowires,
wherein the inorganic nanowires comprise fused inorganic
nanoparticles substantially free of organic scaffold.
In another embodiment, the present invention provides a
method of forming an inorganic nanowire comprising the
steps of: (1) providing one or more precursor materials for the
inorganic nanowire; (2) providing an elongated organic scaf-
fold; (3) reacting the one or more precursor materials in the
presence of the scaffold to form nanoparticles, wherein the
nanoparticles are disposed along the length of the elongated
organic scaffold; and (4) thermally treating the scaffold and
the nanoparticles to form the inorganic nanowireby fusion of
the nanoparticles. In some embodiments, the organic scaffold
can be removed, such as during the thermal treatment. The
present invention also provides nanowires prepared by this
method.
Also providedis a method offorming an inorganic nanow-
ire comprising the steps of: (1) providing one or more pre-
cursor materials for the inorganic nanowire; (2) providing an
organic scaffold; (3) reacting the one or more precursor mate-
rials in the presence of the scaffold under conditions to form
the inorganic nanowire. In some embodiments, the organic
scaffold can be removed, such as during the reacting. The
present invention also provides nanowires prepared by this
method.
The present invention also provides for use ofa filamentous
organic scaffold as a sacrificial organic scaffold in the pro-
duction of an inorganic nanowire comprising providing a
filamentous organic scaffold and an inorganic nanowire pre-
cursor on the scaffold, converting the inorganic nanowire
precursor to the inorganic nanowire while removing thefila-
mentous organic scaffold to yield the inorganic nanowire.
An additional use provided herein is the use ofan elongated
organic scaffold to control the length of an inorganic nanow-
ire disposed thereon, comprising the step of genetically engi-
neering the scaffold to control the length of the scaffold.
An important embodimentis also a device comprising an
electrode in electrical contact with the inorganic nanowire of
embodiment 1 or any other nanowire described herein. In
another embodiment, the device can further compriseat least
two electrodes each in electrical contact with the inorganic
nanowire of embodiment 1 or any other nanowire described
herein. Examples ofdevices include afieldeffecttransistor or
a sensor. In other embodiments, the device comprisesat least
US 8,846,190 B2
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two nanowires according to embodiment 1, or any other
nanowires described herein, wherein the nanowires are in a
parallel arrangement, or in a crossed arrangement.
The invention also provides a segmented nanowire com-
prising a plurality ofconnected segments ofinorganic nanow-
ires of embodiment 1 or any other nanowires described
herein. In some embodiments, the scaffold was used to form
the nanowire and/or direct the placement of the nanowire
before being removed.
The invention also provides a composition comprising a
plurality of inorganic nanowires, wherein the inorganic
nanowires comprise fused inorganic nanoparticles that were
disposed on an organic scaffold. In some embodiments, the
scaffold(s) were used to form the nanowires and/or direct the
placement of the nanowires, such as placementin a circuit
substrate, before being removed.
The invention also provides a process for producing
nanowires with use ofan elongated organic scaffold compris-
ing the steps of: (1) providing an elongated organic scaffold
which comprises a plurality of binding sites including bind-
ing sites along the length ofthe scaffold and bindingsites on
at least one end of the scaffold; (2) disposing a nanowire
precursor composition along the length ofthe scaffold to form
a scaffolded precursor composition; and (3) treating the scaf-
folded precursor composition to form the nanowire. In some
embodiments, the scaffold is substantially removed, such as
during the treating step. In one embodiment, the elongated
organic scaffold has bindingsites at both ends ofthe scaffold.
In another embodiment, the process further comprises the
step ofusing the binding site at the end ofthe scaffold to bind
to anotherstructure. For example, the anotherstructure can be
another elongated organic scaffold.
The invention also provides compositions. For example, in
one embodiment, a nanowire composition is provided com-
prising a nanowire with a thermodynamically high energy
phase, or a collection ofnanowires according to this embodi-
ment, wherein the nanowires are substantially monodisperse
in length, width, or length and width. In this embodiment,the
nanowire can be an inorganic nanowire such as, for example,
a nanowire of semiconductive material, metallic material,
metal oxide material, magnetic material, or mixtures thereof.
The invention also provides an inorganic nanowire com-
prising fused inorganic nanoparticles, or a composition com-
prising a collection of inorganic nanowires accordingto this
embodiment. In this embodiment, the invention also provides
an inorganic nanowire comprising fused inorganic nanopar-
ticles comprising semiconductor material, metallic material,
metal oxide material, or magnetic material, as well as collec-
tions of these nanowires.
Theinvention also provides an inorganic nanowire consist-
ing essentially of fused inorganic nanoparticles that were
disposed on an organic scaffold.
A basic and novel feature for many embodiments of the
present invention is the substantial elimination of the organic
scaffold when it is used to prepare the nanowire. In many
embodiments,its preferred thatthe organic scaffold betotally
eliminated. Moreover, a basic and novel advantage in many
embodimentsis that the nanowires can be fabricated directly
with good monodispersity without use of a size-based sepa-
ration of some nanowires from other nanowires.
BRIEF DESCRIPTION OF DRAWINGS
FIGS. 1A-D illustrate viruses which can be used as scaf-
folds.
FIGS. 2A-F provide characterization ofnanowires made of
semiconductor material.
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FIGS. 3A-F provide characterization ofnanowires made of
magnetic material.
DETAILED DESCRIPTION
I. Introduction
The present invention provides, in one embodiment, an
inorganic nanowire having an organic scaffold substantially
removed from the inorganic nanowire, the inorganic nanow-
ire consisting essentially of fused inorganic nanoparticles
substantially free of the organic scaffold. The present inven-
tion also provides compositions comprising a plurality of
these inorganic nanowires. This invention also provides com-
positions comprising a plurality of inorganic nanowires,
wherein the inorganic nanowires comprise fused inorganic
nanoparticles substantially free of organic scaffold.
The organic scaffold is generally removedso that, prefer-
ably, it cannot be detected on the nanowire. This substantial
removal can be described in terms of weight percentage
remaining. For example, the amount of remaining organic
scaffold with respect to the total amount of nanowire and
scaffold can be less than 1 wt. %, more preferably, less than
0.5 wt. %, and more preferably, less than 0.1 wt. %. A basic
and novelfeature ofthe invention 1s the substantial removal of
the scaffold in the production of high quality nanowires.
In another patent application, which is hereby incorporated
by reference in its entirety, [U.S. Ser. No. 10/665,721 filed
Sep. 22, 2003 to Belcheret al. (“Peptide Mediated Synthesis
ofMetallic and Magnetic Materials”’)], additional description
is provided for burning off and elimination of a viral scaffold
from materials to which the scaffold can selectively bind. In
this application, annealing temperatures of 500-1,000° C. are
described for burning offthe scaffold. In addition, Maoet al.,
Virus-based toolkit for the directed synthesis ofmagnetic and
semiconducting nanowires, Science 303:213-217 (2004),
which is hereby incorporated by reference includingall fig-
ures and the experimental section, includes some teachings
that may be usefulin practicing the present invention.Fairley,
Peter, (2003) Germs That Build Circuits, JEEF Spectrum
37-41, which is hereby incorporated by reference in its
entirety includingall figures and use of electrodes connected
by nanowires, also includes teachings that may be useful in
practicing the present invention, such as applications of
nanowires. Priority provisional application No. 60/534,102
filed Jan. 5, 2004 by Belcheret al., is hereby incorporated by
reference in its entirety.
The detailed description of the invention is organized
accordingto the following sections: (1) introduction,(2) scaf-
fold whichis substantially removed, (3) nanowires, (4) meth-
ods ofmaking nanowires, (5) applications for the nanowires,
and (6) working examples.
II. Scaffold
Although the scaffold ultimately may be substantially
removedfrom the nanowire, the scaffold is an important part
of the invention. In the practice of the present invention, one
skilled in the art can refer to technical literature for guidance
on how to design and synthesize the scaffold including the
literature cited herein and listed at the conclusion of the
specification. For example, although the present invention
relates to organic scaffolds and is not limited only to viral
scaffoldsin its broadest scope, viral scaffolds are a preferred
embodiment. In particular, an elongated organic scaffold can
be used whichis a virus, and the term virus can include both
a full virus and a virus subunit such as a capsid. Theliterature
describes the preparation of viral scaffolds through genetic
engineering with recognition properties for exploitation in
materials synthesis. This includes use of viruses in the pro-
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duction of inorganic materials which have technologically
useful properties and nanoscopic dimensions. In the present
invention, one skilled in the art can use the literature in the
practice ofthe present invention to prepare inorganic nanow-
ires on scaffolds, wherein the scaffoldsare later substantially
eliminated sothat the inorganic nanowire 1s substantially free
ofthe scaffold. When the scaffold is intended to be removed,
the scaffold may be referred to as a “sacrificial scaffold.”
Oneskilled in the art, for example, can refer to the follow-
ing patent literature for selection of the virus, genetic engi-
neering methods,and for materials to be usedwith genetically
engineered viruses. Phage display libraries and experimental
methods for using them in biopanningare further described,
for example, in the following U.S. patent publications to
Belcheret al.: (1) “Biological Control ofNanoparticle Nucle-
ation, Shape, and Crystal Phase”; 2003/0068900 published
Apr. 10, 2003; (2) “Nanoscale Ordering of Hybrid Materials
Using Genetically Engineered Mesoscale Virus”; 2003/
0073104 published Apr. 17, 2003; (3) “Biological Control of
Nanoparticles”; 2003/0113714 published Jun. 19, 2003; and
(4) “Molecular Recognition of Materials”; 2003/0148380
published Aug. 7, 2003, which are each hereby incorporated
by reference in their entirety. Additional patent applications
useful for one skilled in the art describe viral and peptide
recognition studies with use ofgenetically engineered viruses
for materials synthesis and applications including, for
example, (1) U.S. Ser. No. 10/654,623 filed Sep. 4, 2003 to
Belcheret al. (““Compositions, Methods, and Use ofBi-Func-
tional BioMaterials”’), (2) U.S. Ser. No. 10/665,721 filed Sep.
22, 2003 to Belcheret al. (“Peptide Mediated Synthesis of
Metallic and Magnetic Materials”), and (3) U.S. Ser. No.
10/668,600 filed Sep. 24, 2003 to Belcheret al. (‘Fabricated
BioFilm Storage Device”), (4) U.S. provisional Ser. No.
60/510,862filed Oct. 15, 2003 and the U.S. utility application
Ser. No. 10/965,665 filed Oct. 15, 2004 to Belcher etal.
(“Viral Fibers”’); and (5) U.S. provisional Ser No. 60/511,102
filed Oct. 15, 2003 and the U’S. utility application Ser. No.
10/965,227 filed Oct. 15, 2004 to Belcheret al. (Multifunc-
tional Biomaterials . . .””); each ofwhich are hereby incorpo-
rated by reference. These references describe a variety of
specific binding modifications which can be carried out for
binding to conjugate structures, as well as forming the con-
jugate structures in the presence of the material modified for
specific binding. In particular, polypeptide and amino acid
oligomeric sequences can be expressed on the surfaces of
viral particles, including both at the ends and along the length
of the elongated virus particle such as M13 bacteriophage,
including plIII and pVIII expressions, as well as pIX, pVII,
and pVI expressions, and combinations thereof. Using these
expression sights, the viruses may be engineered to express
surface peptides along the length of the virus, at the ends of
the virus, or any numberofother sites and combinations of
sites. A single site for modification can be modified withmore
than one unit for specific binding. For example, a pVIII site
can be modified to have two distinctly different binding units.
In addition, different sites for modification can be modified
with the sameordifferent units for binding. For example, the
endsofthe virus particles can be modified to bindto specifi-
cally bind a first material, while the body ofthe virusparticles
can be modified to bind a second material. Multiple binding
sites can be used to create multifunctional scaffolds that can
be used to form nanowires with specifically engineered and
varying compositions amongotherapplications. The binding
sites can be designed so that nanoparticles nucleate at the
binding sites or the binding sites can be designed to bind
preformed nanoparticles. The scaffold can be functionalized
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with sufficient binding units to achieve the desired concen-
tration needed to form the nanowire.
In addition, the paper “Selection of Peptides with Semi-
conductor Binding Specificity for Directed Nanocrystal
Assembly”; Whaley et al., Nature, Vol. 405, Jun. 8, 2000,
pages 665-668, herein incorporated by reference, describes a
methodof selecting peptides with binding specificity using a
combinatoriallibrary. Specifically, the article shows a method
of selecting peptides with binding specificity to semiconduc-
tor materials using a combinatorial library with about 10?
different peptides. The combinatorial library ofrandom pep-
tides, each containing 12 amino acids, were fusedto theplII
coat protein of M13 coliphage and exposed to crystalline
semiconductor structures. Peptides that bound to the semi-
conductor materials were eluted, amplified, and re-exposed to
the semiconductor materials under morestringent conditions.
Afterthe fifth round of selection, the semiconductorspecific
phages were isolated and sequencedto determinethe binding
peptide. In this manner, peptides were selected with high
binding specificity depending on the crystallographic struc-
ture and composition of the semiconductor material. The
technique can be modified to obtain peptides with a binding
specificity for notjust semiconductor materials, but a range of
both organic and inorganic materials.
Oneskilled in the art can also refer to, for example, C. E.
Flynn et al. Acta Materialia, vol 13, 2413-2421 (2003)
entitled “Viruses as vehicles for growth, organization, and
assembly of materials.” This reference, as well as all refer-
ences cited therein, are incorporated herein by reference in
their entirety. In addition, reference 12 below (Maoetal.,
PNAS) is hereby incorporated by reference for all of its
teachings including the nucleation and structures shown in
FIG. 1. Also, in particular, reference 17 (Flynn etal., J. Mater.
Chem)is also incorporated by reference in its entirety includ-
ing descriptions ofusing aqueoussalt compositionsto nucle-
ate nanocrystals which are directed in their crystal structure
and orientation by the recognition sites. In the present inven-
tion, these nucleated nanocrystals can be converted to single
crystalline and polycrystalline nanowires, wherein the scaf-
fold is substantially removed.
The scaffold is further described including the role of
genetic programming for the preferred embodiments.
Although the viral scaffolds represent a preferred embodi-
ment, the present invention comprises other types ofnon-viral
scaffolds as well. Also, although M13 virus is a preferred
embodimentfor a scaffold, the present invention is not lim-
ited to this virus.
The scaffold can comprise an entire virus, a virion, orviral
subunits including capsids. Viral subunits includingproteins,
peptides, nucleic acids, DNA, RNA,andthe like, in various
combinations. The scaffold does not require that both peptide
and nucleic acid be present. For example, virus mimics can be
used or engineered, wherein the size, shape, or structure
mimicsthat of a virus, but the does not contain nucleic acid
and/or may not havethe ability to infect a hostfor replication.
One skilled in the art can prepare viral scaffolds based on
purely synthetic methods from the bottom up as well as using
moretraditional methods wherein materials are supplied by
nature without or without modification by man.
In a preferred embodiment, wherein the scaffold is a virus
or a virus subunit, the scaffold is tailored and designed in
structure and function by genetic programming and/or
genetic engineering for production of the one dimensional
materials such as nanowires. The genetic programming can
beusedto tailor the scaffold for the particular application, and
applications are described further below. The references in
Section I describe genetic programming which is further
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described in this section for use in practice of the present
invention. See, e.g., Genetically Engineered Viruses, Chris-
topher Ring and E.D.Blair (Eds.), Bios Scientific, 2001, for
descriptions of developments and applications in use of
viruses as vehicles and expressors of genetic material includ-
ing, for example, prokaryotic viruses, insect viruses, plant
viruses, animal DNA viruses, and animal RNAviruses.In the
present invention, genetic programmingcan be carried out to
engineer a scaffold using the different displayed peptide fea-
tures of a virus such as, for example, a filamentous bacte-
riophage such as, for example, the M13 virus which has a rod
shape. Genetic programming can be usedto controlthe scaf-
fold for materials synthesis, the viral scaffold comprising one
or more viral particle subunits which may or may notinclude
the nucleic acid subunit ofthe virus. Also, the scaffold may or
may notretain infectability.
An overall commercial advantage to this genetic program-
ming approach to materials engineering, in addition to mate-
rials-specific addressability, is the potential to specify viral
length and geometry. For example, an elongated organic scaf-
fold maybe genetically engineered to control the length ofthe
scaffold. This engineering of length can allow the design of
nanowires of specific, controlled lengths, for example.
Hence,a variety of methods can be used to control the scaf-
fold length and geometry.
For example, the length of a filamentousvirusis generally
related to the size of its packaged genetic information and the
electrostatic balance between the pVIII-derived core of the
virion and the DNA.See,e.g., B. K. Kay, J. Winter, J. McCaf-
ferty, Phage Display of Peptides and Proteins: A Laboratory
Manual, AcademicPress, San Diego, 1996; Greenwoodet al.,
Journal of Molecular Biology 217:223-227 (1992). Phage
observed by AFM generally are seen to be roughly 860 nm
and as short as 560 nm depending on whether the complete
M13 genomeor smaller phagemid are used in sample prepa-
ration. See, e.g., reference 12, C. Mao, C. E. Flynn, A. Hay-
hurst, R. Sweeney,J. Qi, J. Williams, G. Georgiou, B. Iverson,
A.M.Belcher, Proc. Natl. Acad. Sci. 2003, 100, 6946. Also,
changing a single lysine to glutamine on the inner-end of
pVIII can result in particles approximately 35% longer than
wild type phage. See, e.g., J. Greenwood, G. J. Hunter, R. N.
Perham, J. Mol. Biol. 1991, 217, 223.
In addition, specific linkage, binding, and concatenation of
virus particles can help produce longerviral scaffolds, and
thus longer nanowires. The multiplicity of additions can be
controlled by engineering binding motifs into one virus,
which then can accurately recognize bindingsites on another
virus. For example, the pill protein resides at one end of the
M13 virus and can be exploited to display peptide and protein
fusions. At the other end of the virus, the pIX and pVII
proteins also can be subject to modification. For example,
Gao and coworkers utilized pIX and pVII fusions to display
antibody heavy- and light-chain variable regions. [See, e.g.,
C. Gao, S. Mao, G. Kaufmann, P. Wirsching, R.A. Lerner, K.
D. Janda, Proc. Natl. Acad. Sci. 2002, 99, 12612] See,also,
for example, U.S. Pat. No. 6,472,147 for genetic modification
of viruses. These end modifications may be usedto link the
virus particles directly or the end modifications may specifi-
cally bindto a linker. The linker maybe any suitable material.
For example, the linker can be a nanoparticle, amino acid
oligomer, nucleic acid oligomer, or a polymer. This present
invention encompassesdual-endviral display, either for gen-
erating bimodal heterostructures, or in combination with
pVIII, producing end-functionalized nanowires.
In addition, dual-end directional linkages enable creation
of other interesting and commercially useful geometries,
such as rings, squares and other arrays. The binding of one
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end ofa virusdirectly to the other endofthe virus withoutthe
use of a linker can be used to form rings, wires, or otherviral
basedstructures as well. By engineering recognitionsites and
the corresponding conjugate moieties into a single virus, or
multiple viruses, the entire system can be genetically pro-
grammed.
An important advantageofthe inventionis that the organic
scaffold can be an active scaffold, wherein the scaffold not
only serves as a template for synthesis of the inorganic
nanowire, but also actively assists in coupling the inorganic
nanowireto otherstructures. For example, an organic scaffold
whichis designed at one end to bind to anotherstructure can
be used to couple the inorganic nanowire to the structure. The
scaffolds and the nanowires can be coupled to each other, for
example, to form segments of similar or dissimilar materials.
In this embodiment, the composition of the nanowire would
vary as a function of length.
Additional description is provided for the types of viral
structures which can be designedby genetic programmingfor
particular applications based on length control, geometry
control, binding control, and the like. The virusscaffoldis not
particularly limited, and combinationsofviruses can be used
of different types. In general, viruses can be used which can
be multifunctionalized. In general, virus particles which are
long, filamentous structures can be used. See, e.g., Geneti-
cally Engineered Viruses, Christopher Ring (Ed.), Bios Sci-
entific, 2001, pages 11-21. Additionally, other viral geom-
etries such as dodecahedral and icosahedral can be
multifunctionalized and used to create composite materials.
Virus particles which can function as flexible rods, forming
liquid crystalline and otherwise aligned structures, can be
used.
In particular, phage display libraries, directed evolution,
and biopanning are an importantpart ofgenetic programming
ofviruses, and viruses can be used which have been subjected
to biopanning in the viral design so that the virus particles
specifically can recognize and bind to materials which were
the object ofthe biopanning. The materials can also be nucle-
ated and synthesized in particulate form, including nanopar-
ticulate form, in the presence of the specific recognition and
binding sites. Use of filamentous virus in so called directed
evolution or biopanning is further described in the patent
literature including, for example, U.S. Pat. Nos. 5,223,409
and 5,571,698 to Ladneret al. (“Directed Evolution ofNovel
Binding Proteins”). Additional references on the recognition
properties of viruses include U.S. Pat. No. 5,403,484 (phage
display libraries, now commercially available) and WO
03/078451.
Mixtures of two or more different kinds of viruses can be
used. Mixtures ofvirus particles with non-virus materials can
be used in forming materials which usethe present invention.
Virus andvirus particle can include both an entire virus and
portions ofa virus includingat least the virus capsid. The term
virus can refer to both viruses and phages. Entire viruses can
include a nucleic acid genome, a capsid, and mayoptionally
include an envelope. Viruses as described in the present
invention may further include both native and heterologous
amino acid oligomers, such as cell adhesion factors. The
nucleic acid genome may beeither a native genome or an
engineered genome.A virusparticle further includes portions
of viruses comprising at least the capsid.
In general, a virus particle has a native structure, wherein
the peptide and nucleic acid portionsofthe virus are arranged
in particular geometries, which are sought to be preserved
whenit is incorporated in solid state, self supporting forms
such asfilms and fibers.
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Viruses are preferred which have expressed peptides,
including peptide oligomers and amino acid oligomeras spe-
cific binding sites. Amino acid oligomers can include any
sequence of amino acids whether native to a virus or heter-
ologous. Amino acid oligomers may be any length and may
include non-amino acid components. Oligomers having
about 5 to about 100, and moreparticularly, about 5 to about
30 amino acid units as specific binding site can be used.
Non-amino acid components include, but are not limited to
sugars, lipids, or inorganic molecules.
The size and dimensionsofthe virus particle can be such
that the particle is anisotropic and elongated. Generally, the
viruses may be characterized by an aspectratio ofat least 25,
at least 50, at least 75, at least 100, or even at least 250 or 500
(length to width, e.g, 25:1).
A wide variety of viruses may be used to practice the
present invention. The compositions and materials of the
invention may comprise a plurality ofviruses of a single type
or a plurality of different types of viruses. Preferably, the
virus particles comprising the present invention are helical
viruses. Examplesofhelical viruses include, but are not lim-
ited to, tobacco mosaic virus (TMV), phage pfl, phage fdl,
CTX phage, and phage M13. These viruses are generally
rod-shaped and mayberigid or flexible. One of skill in the art
mayselect viruses depending on the intended use and prop-
erties of the virus.
Preferably, the viruses of the present invention have been
engineered to express one or more peptide sequencesinclud-
ing amino acid oligomers on the surface of the viruses. The
amino acid oligomers may benative to the virusor heterolo-
gous sequences derived from other organisms or engineered
to meet specific needs.
A numberofreferences teach the engineering ofviruses to
express amino acid oligomers and may be usedto assist in
practicing the present invention. For example, U.S. Pat. No.
5,403,484 by Ladneret al discloses the selection and expres-
sion of heterologous binding domains on the surface of
viruses. U.S. Pat. No. 5,766,905 by Studieret al discloses a
display vector comprising DNA encodingatleast a portion of
capsid protein followed by a cloning site for insertion of a
foreign DNA sequence. The compositions described are use-
ful in producing a virus displaying a protein or peptide of
interest. U.S. Pat. No. 5,885,808 by Spooneret al discloses an
adenovirus and method of modifying an adenovirus with a
modified cell-binding moiety. U.S. Pat. No. 6,261,554 by
Valerio et al shows an engineered gene delivery vehicle com-
prising a gene of interest and a viral capsid or envelope
carrying a memberofa specific binding pair. U.S. Published
Patent Application 2001/0019820 by Li showsviruses engi-
neered to express ligandsontheir surfaces for the detection of
molecules, such as polypeptides, cells, receptors, and channel
proteins.
The genetically engineered viruses can be prepared by
methods and vectors as described in Kay, B. K.; Winter, J.;
McCafferty, J. Phage Display of Peptides and Proteins: A
Laboratory Manual; Academic Press: San Diego, 1996, and
in particular, chapter 3, “Vectors for Phage Display” and
references cited therein. In addition, the genetically engi-
neered viruses can be prepared by methodsas described in,
Phage Display, A Laboratory Manual, by Barbaset al. (2001)
including Chapter 2, “Phage Display Vectors” and references
cited therein. The type of vector is not particularly limited.
Table 2.1 ofBarbas provides exemplary vectors which can be
used in various combinations to provide the multifunctional
viruses. For example, type 3, type 8+8, and phagemid type
p7/p9 can be combined.Or type 8 and type 3 can be combined
along with phagemid p7/p9 as desired. One skilledin the art
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can develop other combinations based on particular applica-
tions. Methods can be developedto either display the peptide
on someor substantially all copies of the coat protein.
M13 systems are a preferred example of a filamentous
virus scaffold, but other types of filamentous virus scaffolds
can be used as well. The wild type filamentous M13 virus is
approximately 6.5 nm in diameter and 880 nm in length. The
length of the cylinder reflects the length of the packaged
single stranded DNA genomesize. At one end of M13 virus,
there are approximately five molecules each of protein VII
(pVIJ) and protein IX (pIX). The other end has about five
molecules each of protein III (pI) and protein VI (pVJ),
totaling 10-16 nm in length. The wild type M13virus coatis
composed of roughly 2800 copies of the major coat protein
VIL (pVII) stacked in units of 5 in a helical array.
In sum, evolution of substrate specific peptides through
phage display technologies for the directed nucleation of
materials on the nanometer scale has been previously
reported by papers and patents from Angela Belcher and
coworkers (see above description) and serves as the basis for
the material specificity in the virus scaffold or template (16)
of the present invention. Screening phage libraries for the
ability to nucleate and assemble inorganic systemsincluding,
for example, the ZnS, CdS (12, 17), FePt and CoPt systems
(18) using commercially available bacteriophage libraries
expressing either a disulphide constrained heptapeptide or a
linear dodecapeptide, has yielded the consensus sequences
CNNPMHQNC (termed A7; ZnS), SLTPLITSHLRS
(termed J140; CdS), HNKHLPSTQPLA (termed FP12;
FePt), andACNAGDHANC(termed CP7; CoPt). Incorpora-
tion of these peptides into the highly ordered, self assembled
capsid of the M13 bacteriophagevirus provides a linear tem-
plate which can simultaneously control particle phase and
composition, while maintaining an ease of material adapt-
ability through genetic tuning of the basic protein building
blocks. Because the protein sequences responsible for the
materials growth are gene linked and contained within the
capsid of the virus, exact genetic copies of this scaffold are
relatively easily reproduced by infection into a large suspen-
sion of bacterial hosts.
To prepare nanowires, an anisotropic scaffold can be used
which hasthe ability to collect nanoparticles being formed
around it and locate them on the scaffold for fusion into a
nanowire.In this invention, an inorganic nanowire composi-
tion can be formed having a scaffold substantially removed
from the inorganic nanowire. Non-viral scaffolds can also be
used including, for example, a variety of other organic scaf-
folds including, for example, scaffolds which have peptide or
protein recognition units as side groups on an organic back-
bone. For example, the organic backbone can be a synthetic
polymer backbone, which are well knownin the art. For
example, polymer scaffolds can be used including for
example modified polystyrenes ofuniform molecular weight
distribution which are functionalized with peptide units.
Another example is branched polypeptides or nucleic acids
which are modified to have recognition sites. Another
example is a nanolithographically printed peptide structures
such as a line with nanoscale width. In general, DNA, pro-
teins, and polypeptides can be modified with recognition
units, including peptide recognition units, to function as the
organic scaffold. Suitable recognition units include, but are
not limited to, amino acid oligomers, nucleic acid oligomers,
polymers, organic molecules(e.g., antibodies, antigens, cell
adhesion factors, and trophic factors), and inorganic materi-
als.
In one embodiment, scaffolds and virus particles can be
used whichare notdirectly genetically engineered. However,
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in general, desirable properties can be achieved when the
virus is genetically engineered or genetic engineering is used
in designing the scaffold.
III. Nanowires
Using methods describedin the previous sections, viruses
can be genetically engineered so that they function as a scaf-
fold and bind to conjugate moieties in an overall process
which ultimately yields a production of inorganic nanowires
accordingto the present invention. For example, a rod-shaped
virus can direct the synthesis of nanoparticulates materials
along the length of the rod, and these nanoparticulates mate-
rials can be fused into nanowires.
In the present invention, the conjugate materials can be
inorganic materials which form nanoparticles including inor-
ganic nanocrystals. From these inorganic nanoparticles, inor-
ganic nanowires can be formed consisting essentially of the
fused inorganic nanoparticles upon substantial removalofthe
scaffold. The conjugate materials and the inorganic nanow-
ires can consist essentially oftechnologically useful materials
such as, for example, semiconducting materials, whether
doped or undoped; metallic materials; metal oxide materials,
and magnetic materials. Various oxide materials including
silica and alumina fall within the scope of the invention.
Additional materials of interest for nanotechnology commer-
cial applications are further described in, for example: (a)
Understanding Nanotechnology, Warner Books, 2002,
including materials for circuits such as nanowires and nano-
tubes described in the chapter “The Incredible Shrinking
Circuit”, pgs. 92-103 by C.Lieber. (b) Made to Measure, New
Materialsfor the 21st Century, Philip Ball, Princeton Univer-
sity, (c) Introduction to Nanotechnology, C. P. Poole Jr., F. J.
Owens, Wiley, 2003. Preferably, for nanowires, the materials
prepared on the scaffold conductelectricity as an electrical
conductor, are semiconductive (whether inherently or via
doping), transmit light, are magnetic, or possess some other
technologically useful property. Other properties includefer-
roelectric, piezoelectric, converse-piezoelectric, and thermo-
electric).
Semiconductors are a particularly important type of inor-
ganic nanowire material. The semiconductor materialcan be,
for example, any of the standard types including alloys
thereof including IV-IV Group (e.g., Si, Ge, II-V Group
binary (e.g., GaN, GaP), II-V Group temary (e.g.,
Ga(As,__,P..)), I-VI Group binary (e.g., ZnS, ZnSe, CdS,
CdSe, CdTe), IV-VI Group binary (e.g., PbSe), transition
metal oxides (e.g., BiTiO,), and combinations thereof.
Magnetic materials can be those knownin theart including
nanostructured magnetic materials. See, for example, Jntro-
duction to Nanotechnology, C. P. Poole Jr, F. J. Owens,
Wiley, 2003, Chapter 7, pages 165-193 (“Nanostructured Fer-
romagnetism) and references cited therein (see, e.g., page
193).
In general, although the present inventionis not limited by
theory, and the mechanism ofnanowire formation is not fully
understood, the nanowires can be structures wherein the
nanoparticles form into nanowires and collapse into a fused
structure at the end ofthe process. The porosity ofthe nanow-
ire is not particularly limited, but in general, non-porous
nanowire materials are preferred, particularly for conductive
applications wherein porosity could interfere with desired
conductivity.
The nanowire can be crystalline. The nanowire can be a
single crystalline domain or can have one or morecrystalline
domains. In one embodiment, the fused nanoparticles are
single crystalline. The crystalline phase can be either the
thermodynamically favorable crystalline state or a crystalline
state which is not thermodynamically favorable but is locked
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in by therelative orientation of the crystalline nanoparticles
before fusion. The nanoparticles can be oriented in any man-
ner. For example, the crystallographic axis of the nanopar-
ticles can be oriented with respect to the surface of the scaf-
fold. One can vary the thermal treatment in the method of
making (see below)to achieve a desired crystalline structure,
or to covert polycrystalline structures to single crystalline
structures. One can also vary the thermaltreatment to remove
the organic scaffold. In some cases fusion and organic scaf-
fold removalare achieved at the same temperature, in other
cases, fusion can occur before removal.
The length ofthe nanowire can be, for example, about 250
nm to about 5 microns, or moreparticularly, about 400 nm to
about 1 micron.
The width ofthe nanowire can be, for example, about 5 nm
to about 50 nm,or moreparticularly, about 10 nm to about 30
nm.
In some embodiments, the length of the nanowire can be,
for example, about 250 nm to about 5 microns, and have a
width, for example, of about 5 nm to about 50 nm.In other
embodiments,the length ofthe nanowire can be, for example,
about 5 nm to about 50 nm,and have a width, for example, of
about 10 nm to about 30 nm.
Whena plurality of nanowires is present, the lengths and
widths can be expressed as average lengths and widths using
knownstatistical methods in materials science. For example,
the average length ofthe nanowire can be, for example, about
250 nm to about 5 microns, or more particularly, about 400
nm to about 1 micron. The average width ofthe nanowire can
be, for example, about 5 nm to about 50 nm,or more particu-
larly, about 10 nm to about 30 nm.
Also, whena plurality of nanowiresis present, the nanow-
ires can be substantially monodispersein length and/or width.
The monodispersity can be accomplished, because the
nanowires are assembled from scaffolds with uniform length
and width. Again, knownstatistical methods in material sci-
ence can be used to calculate the polydispersity for length and
width. For example, images ofthe nanowires can be obtained
and, for example, 20-50 nanowires can be selected for statis-
tical analysis. The coefficient ofvariation (CV) can be calcu-
lated wherein the standard deviation is divided by the mean.
The CV can be, for example, less than about 20%, more
preferably, less than about 10%, more preferably, less than
about 5%, and more preferably, less than about 3%.
The nanowires can be substantially straight. For example,
straightness can be estimated by (1) measuring the true length
of the nanowire, (2) measuring the actual end to end length,
(3) calculate the ratio of true length to actual end to end
length. For a perfectly straight nanowire, this ratio will be
one. In the invention, ratios close to one can be achieved
including, for example, less than 1.5, less than 1.2, and less
than 1.1.
The inorganic nanowires of the present invention can also
be formed in combination with other types ofconjugate mate-
rials to form larger structures using, for example, multifunc-
tional scaffolds. Hence, the conjugate material is not particu-
larly limited to inorganic materials for these larger structures
and combinations of materials can be used. In general, it will
be selected for a particular application. It can be selected so
that the virus particles can be subjected to biopanning against
the conjugate material, and then the conjugate material is
selectively or specifically boundto the virusparticle. In some
applications, selective binding can be sufficient, whereas in
other applications, a more powerful specific binding can be
preferred. Examples of general types of conjugate materials
which can be used in larger structures include inorganic,
organic, particulate, nanoparticulate, single crystalline, poly-
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crystalline, amorphous, metallic, magnetic, semiconductor,
polymeric, electronically conducting, optically active, con-
ducting polymeric, light-emitting, and fluorescent materials.
Conjugate materials are described further, for example, in the
patent publications and technicalliterature to Angela Belcher
and co-workers cited throughoutthis specification.
In sum,the present invention relates to the general, univer-
sal synthesis of 1-D nanostructures, including nanowires,
based on, in preferred embodiments, a genetically modified
virus scaffold for the directed growth and assembly of crys-
talline nanoparticles into 1-D arrays, followed by annealing
of the virus-particle assemblies into high aspectratio, crys-
talline nanowires through oriented, aggregation-basedcrystal
growth (14, 15) (FIG. 2A). The synthesis of analogous
nanowire structures from fundamentally different materials,
e.g., the II-VI semiconductors ZnS and CdS and the L1,
ferromagnetic alloys CoPt and FePt, demonstrates both the
generality of the virus scaffold and the ability to precisely
control material characteristics through genetic modification.
In contrast to other synthetic methods (6), this approach
allows for the genetic control of crystalline semiconducting,
metallic, oxide, and magnetic materials with a universal scaf-
fold template.
IV. Method of Making Inorganic Nanowires
Thepresent invention also provides methods ofmaking the
inorganic nanowires, which are further exemplified in the
below working examples. For example, the invention pro-
vides a method offorming an inorganic nanowire comprising
the stepsof: (1) providing one ormore precursor materials for
the inorganic nanowire; (2) providing an elongated organic
scaffold; (3) reacting the one or more precursor materials in
the presence of the scaffold to form nanoparticles, wherein
the nanoparticles are disposed along the length of the elon-
gated organic scaffold; and (4) thermally treating the scaffold
and the nanoparticles to form the inorganic nanowire by
fusion of the nanoparticles. In some embodiments, the ther-
mal treatmentis not performed, and the method comprises the
stepslisted as (1)-(3) above. This method offorming a nanow-
ire can also be used to form a plurality of nanowires.
In these methods, the inorganic nanowires are described in
the previous section including the crystallinity, types ofmate-
rials, size including length and width, monodispersity, and
straightness. Also, in these methods, the elongated organic
scaffold is described above includingthe viral system with its
potential for selective recognition. These methods include
situations involving the substantial removal of the organic
scaffold.
The invention is not particularly limited by the type of
reaction and the precursor materials used to form the nanow-
ire. In general, the reaction andthe precursor materials should
be compatible with the scaffold. Reactions at temperatures of
below 100° C. can be used to form the nanoparticles. In a
preferred embodiment, the treating step comprises a chemical
reduction of metal precursor salts. Precursor material can be
preformed nanoparticles or materials that form nanoparticles,
for example.
In a preferred embodiment, the nanoparticles can have an
average diameter of about 2 nm to about 10 nm, and more
particularly, about 3 nm to about 5 nm. The nanoparticles can
be crystalline before and/or after the thermal treating. The
nanoparticles can be fused before and/or after thermaltreat-
ment. For example, the thermal treatment mayact to fuse the
nanoparticles, which were not fused prior to the thermal
treatment. The nanoparticles can be oriented or not oriented.
The temperature and time ofthe thermaltreatmentstep are
not particularly limited but can vary depending on the pre-
cursor materials used and the material of the final nanowire.
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For example, the melting temperatures and annealing behav-
ior of the materials can be considered in selecting tempera-
ture. In general, temperatures of about 100° C. to about
1,000° C. can be used. Thermal treatment can be usedto fuse
the nanoparticles into a single structure and also to remove the
scaffold, tailored for a particular application with particular
materials. In principle, the porosity of the nanowire and the
degree of fusion of the nanoparticles can be affected by the
temperature. In a preferred embodiment, the thermaltreat-
mentstep can be carried out at about 300° C.or higher, up to
about 500° C. In general, and depending on the materials,
lower temperatures can be used such as, for example, about
200° C. to about 300° C. ifmore porous nanowiresare desired
with less fusion. The thermaltreatmentstep can be carried out
at a temperature below the melting temperature ofthe precur-
sor material. The temperature can be selected to achieve a
desired crystalline phase which maybe a low energy phase or
a high energy phase. If desired, a temperature programming
step can be usedtotailor the fusion of the nanoparticles, the
targeted crystal phase, and the removal of the scaffold, if
desired. Higher temperatures of, for example, about 500° C.
to about 1,000° C. can be used to ensure the scaffold is
completely removed and burned off. Lower temperatures, for
example, about 50° C. to 300° C., can be used to avoid
removing the scaffold. However, temperature and time can be
selected so as to not result in excessive oxidation of the
nanowires. The time of the thermaltreatment is not particu-
larly limited but can be, for example, 30 minutes to 12 hours.
Preferably, the temperature and time for thermal treatment
can be adjusted to achieve the optimum balance for nanopar-
ticle fusion while reducing oxide formation and improving
the stability of the crystal structure.
In one embodiment, the invention provides a process for
producing nanowires with use of an elongated organic scaf-
fold comprising the steps of: (1) providing an elongated
organic scaffold which comprises a plurality of bindingsites
including binding sites along the length of the scaffold and
bindingsites on at least one end ofthe scaffold; (2) disposing
a nanowire precursor composition along the length of the
scaffold to form a scaffolded precursor composition; and (3)
treating the scaffolded precursor composition to form the
nanowire. In one embodiment, the elongated organic scaffold
has binding sites at both ends of the scaffold. In another
embodiment, the process further comprises the step of using
the binding site at the end of the scaffold to bind to another
structure. The other structure can be, for example, another
elongated organic scaffold. an electrode, a circuit element, a
semiconductor material, an electrically conductive material,
a magnetic material, or a biological molecule. The scaffold
can be boundto a patterned structure, such as a circuit sub-
strate. The treating step may be a thermaltreatment step as
described in detail herein. The scaffold can be removedorleft
intact.
V. Applications
The nanowiresofthe present invention canbe used inmany
different commercial applications, some of which are noted
above, includingthe cited patent applications, and in the cited
referencesat the end of the specification. The nanowires can
be used, for example, in applications requiring electrical con-
ductivity or semiconductivity at the nanoscale. The large
surface area to volumeratio ofnanowires is advantageousfor
applications, such as,fule cells, thin film batteries, and super-
capacitors. In some applications, a single nanowire can be
used. In other applications, a plurality of nanowires can be
used, whether in a parallel or crossed manner. In general,
organized arrangements of nanowires are advantageous. In
some applications, the nanowire can be surface modified,
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doped, or otherwise modifiedin its material structure for the
application. Modifications include both chemical and bio-
logical modifications. Microcircuitry, nanocircuitry, macro-
electronics, photovoltaics, solar cells, chemical and biologi-
cal sensors, optical components, field emitting tips and
devices, nanocomputing, nanoswitches, molecular wire
crossbars, batteries, fuel cells, catalysts, very large flat panel
displays, tiny radio frequency identification devices, smart
cards, phased array RF antennas, disposable computing and
storage electronics, nanoscale bar codes, cross bar nanostruc-
tures, biosensorarrays, high density data storage, field effect
transistors, and the like are representative examples of appli-
cations for the nanowires. Particularly important semicon-
ductive elements include, for example, p-n diodes, p-i-n
diodes, LEDs, and bipolar transistors. Nanowires can be
incorporated into a number of devices, such as electronic,
optoelectronic, electrochemical, and electromechanical
devices. A single nanowire can connect elements in a device
or a series of connected segments of nanowires can connect
elements. For example, a field effect transistor device may
comprise nanowires in both a parallel and crossed arrange-
ment.
Applications of nanowires are described in, for example,
USS. patent application publication no. 2003/0089899 (pub-
lished May 15, 2003) to Lieberet al. and include, for example,
field effect transistors, sensors, and logic gates, and this pub-
lication is hereby incorporated by reference in its entirety
including its description of devices made from nanowires.
Additional applications of nanowires are described in, for
example, U.S. patent application publication no. 2003/
0200521 (published Oct. 23, 2003) to Lieber et al. and include
nanoscale crosspoints, which is incorporated by reference in
its entirety. Additional applications of nanowires are
describedin, for example, U.S. patent application publication
no. 2002/0130353 (published Sep. 19, 2002) to Lieberet al.
and include devices with chemical patterning and bistable
devices. Additional applications of nanowires are described
in, for example, U.S. patent application publication no. 2002/
0117659 (published Aug. 29, 2002) to Lieber et al. and
include nanosensorsfor chemical and biological detection. In
addition, applications for related nanorods are described in,
for example, U.S. Pat. Nos. 6,190,634; 6,159,742; 6,036,774;
5,997,832; and 5,897,945 to Lieber et al. A numberoflitera-
ture references teach applications of nanowires and related
technology, such as Choi et al., J. Power Sources 124:420
(2003); Cuiet al., Science 293:1289-1292 (2001); De Heeret
al., Science 270:1179-1180 (1995); and Dominko et al.,
Advanced Materials 14(21):1531-1534 (2002), which all of
whichare herein incorporated by reference in their entirety.
Ofparticular importance for this invention,the scaffold can
be used to direct the nanowire to other structures so the
scaffold is an active scaffold rather than a passive scaffold.
For example, viruses can be conjugated with one-dimen-
sional nanowires/nanotubes, two dimensional nano elec-
trodes, and microscale bulk devices. One-dimensional mate-
rials, such as nanotubes or nanowires, when conjugated with
the pIII end ofM13 viruses, may form phase separated lamel-
lar structures that have inorganic nanotubeornanowire layers
and phage building block layers. Two-dimensional nano-
thick plate shaped electrodes can be organized. Viral-semi-
conductor composite nanowires can be attached across metal
electrodes, including noble metal electrodes such as gold
electrodes, through binding sites at either end of the virus.
The nanowire can bridge a source and a drain. The nanowire
precursor can be disposed on or adjacentto the electrodes and
then the scaffold can be removedso that the nanowire can be
intimately in electrical contact with the electrode in a final
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state. The thermal annealing can becarried outpriorto bridg-
ing the electrodes with the nanowire or after bridging the
nanowireto the electrodes, as long as the nanowire ultimately
functions as a bridge. These structures can function as nano-
FET devices with enhanced performance dueto the c.a. 5 nm
diameter ofthe gate region. Unlike other proposed nano-scale
devices, where wire placement must be donestochastically,
this approach directs single wires to the correct electrode
locations. Alternative cathode and anode structures might be
useful for nanosize biofuel cells. When the specific binding
M13 virus combined with micro-size objects, periodic orga-
nization of these micro-dimensional objects is also possible.
Therole ofthe M13 virus will be the specific adhesive unit to
self-assemble multiple different objects in periodic patterns.
The engineering ability of the M13’s various proteins can be
a key factor in the development of these viral-inorganic
hybrid-basedarrays.In addition,fibersor fabric like networks
of viruses can be constructed with specifically designed
mechanical properties based on the secondary andtertiary
structures induced by viral-viral binding. In addition these
materials can have special properties impregnated into them
by further functionalizing the viruses to bind regentsor sig-
naling elements.
Additionally, multifunctional viral based arrays can have
uses in tissue repair where onepart of the array selectively
bindsto a tissue type where anotherpart can nucleate bone or
other structural bio-materials. Additionally, catalytic nano-
structures can be developed by controlling elementalidentity
and geometrical arrangementofmolecular catalytic moieties.
The exploitation of the self-assembly motifs employed by
the M13 bacteriophage to produce a biological scaffold pro-
vides methods of generating a complex, highly ordered, and
economical template for the general synthesis of single crys-
tal nanowires. By introducing programmable genetic control
over the composition, phase and assembly ofnanoparticles, a
generic template for the universal synthesis of a variety of
materials can be realized. Further advancesin the fabrication
of nanoscale materials and devices can be achieved through
modification of the remaining four proteins in the virus to
incorporate device-assembly directors. The ability ofviruses
to form liquid crystal and otherwise aligned and ordered
systems, based on their shape anisotropy, is another promis-
ing route for the assembly ofvirus-based nanowiresinto well
ordered arrays on multiple length scales (11). Overall, modi-
fication ofbiological systems by the introduction of substrate
specific peptides presents a method of achieving well ordered
nanomaterials in a cost-effective and scalable manner.
In particular, when aminoacid oligomers are expressed on
a surface, the expression of the amino acid oligomers may
serve a number of commercially useful functions, including
but not limited to, cell adhesion factors, trophic factors, or
binding sites for organic or inorganic molecules. Expression
of amino acid oligomers allows the viruses to be engineered
to specific applications. For example, the films or fibers com-
prising engineered fibers may contain amino acid oligomers
that initiate or enhance cell growth for use in tissue engineer-
ing applications. In another example, amino acid oligomers
with specificity for a specific inorganic molecule may be
expressedto bind the inorganic molecule to increase the effi-
ciency of a chemical reaction. In still another example, the
expressed amino acid oligomer may bind an organic mol-
ecule, such as a biodefense agent. Such filmsor fibers could
be incorporatedinto the clothing ofmilitary personnelorfirst
responders as part of a sensor system.
These are only a few examplesofthe utility of films and
fibers made from engineered viruses, and other applications
are readily apparent to one ofskill in the art.
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Working Examples
The present invention is further characterized by the fol-
lowing non-limiting working examples including FIGS. 2
and 3 and description and discussion thereof. One skilled in
the art can use as guidance FIGS. 1-3 in the practice of the
present invention which provide an introduction to the work-
ing examples.
FIG. 1
FIG. 1A illustrates the nanowire synthesis scheme or the
nucleation, ordering and annealing of virus-particle assem-
blies. FIG. 1B showsthe symmetry ofthe virus. The symme-
try allows for ordering of the nucleated particles along the x,
y, and z directions fulfilling requirements for aggregation
based annealing. FIG. 1C showsthe highly ordered nature of
the M13 bacteriophage. The highly ordered natureoftheself
assembled M13 bacteriophage promotesthe preferred orien-
tation seen in nucleated particles through the rigidity and
packing ofthe expressed peptides, which is visualized at 20%
incorporation. FIG. 1D showsthe construct of the M13 bac-
teriophage virus. The construct has genetically modifiable
capsid and ends, specifically the gPVII, gPHI, and gPIX,
which are coded for in the phagemid DNA enclosed within
the virus capsid.
FIG. 2
FIGS. 2A-F shows electron microscopy of both the pre-
and post-annealed ZnS and CdS viral nanowires. FIG. 2A
shows Dark-field Diffraction-contrast imaging of the pre-
annealed ZnS system using the (100) reflection reveals the
crystallographic ordering of the nucleated nanocrystals,
where contrast stems from satisfying the (100) Bragg diffrac-
tion condition. The inset of FIG. 2A showsthe ED pattern of
the polycrystalline pre-annealed wire showing the wurtzite
crystal structure and the single crystal type [001] zone axis
pattern, suggesting a strong zoneaxis preferred orientation of
the nanocrystals on the viral template. The electron diffrac-
tion (ED)pattern (inset ofFIG. 2A) showssingle crystal-type
behavior, even though the sample area is composed of many
nanocrystals. This behavior suggests that the nanocrystals on
the virus were preferentially oriented with their c-axes per-
pendicularto the viral surface. FIG. 2B is a Bright-field TEM
image of an individual ZnS single crystal nanowire formed
after annealing. The upperleft inset of FIG. 2B shows the ED
pattern along the [001] zone axis showsa single crystal wurtz-
ite structure of the annealed ZnS nanowire. The lowerright
inset of FIG. 2B is a low magnification TEM image showing
the monodisperse, isolated single crystal nanowires. FIG. 2C
shows a typical HRTEM of a ZnSsingle crystal nanowire
showing alatticeimage that continually extends the length of
the wire, confirming the single crystal nature ofthe annealed
nanowire. The measured lattice spacing of 0.33 nm corre-
sponds to the (010) planes in wurtzite ZnS crystals. A 30°
orientation of(010) lattice planes with respect to the nanowire
axis is consistent with the (100) growth direction determined
by ED. FIG. 2D HAADF-STEMimageofsingle crystal ZnS
nanowires, which were annealed on a silicon wafer. FIG. 2E
shows HAADF STEM imagesof CdSsingle crystal nanow-
ires. FIG. 2F is an HRTEMlattice imageofan individual CdS
nanowire. The experimentallattice fringe spacing, 0.24 nm,is
consistent with the unique 0.24519 nm separation between
two (102) planes in bulk wurtzite CdS crystals.
FIG. 3
FIG. 3A shows CoPt wires as synthesized by the modified
virus template where soluble in water. Reduction ofCo and Pt
salts without the presence of the virus yielded large precipi-
tates which immediately fell out of solution. FIG. 3B shows a
TEM imageofthe unannealed CoPt system. The inset ofFIG.
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3B shows a STEM image of unannealed CoPt wires. The
scale bar shown is 100 nm. FIG. 3C showsa low resolution
TEM image of crystalline L1, CoPt wires (about 650
nmxabout 20 nm). The tendency of the CoPt and FePt wires
to not be straight may stem from magnetic interactions
between wires and/or nanoparticles not present in the II-VI
systems. The inset of FIG. 3C is an ED showingthe charac-
teristic (110) and (001), L10 lines, and the crystallinity ofthe
system. FIG. 3D is an HRTEM of the CoPt wires with the
(111) plane perpendicular to the c-axis of the wire. The inset
ED reveals the superlattice structure unique to the L10 phase.
FIG. 3Eis a TEM imaging ofthe unannealed FePt wires. FIG.
3F shows a TEM ofthe annealed FePt wires. The inset ED
pattern confirms the L10 nature of the FePt wires and shows
the crystalline nature of the material.
Engineering M13 Bacteriophage
The M13 bacteriophage used in the working examplesis a
high production rate virus (200 mg/L) comprised of five
genetically modifiable proteins (19, 20, 21); gene products
(gP)-3, 6, 7, 8 and 9, ofwhich ~2700 copiesofthe gP8 protein
formsthe capsid of the wild type virus. The gP8 protein was
genetically modified and expressed using a phagemid system,
resulting in fusion of the substrate specific peptides to the
N-terminusof the gP8 protein (12). During assembly, stack-
ing of the gP8 unitcell results in a five-fold symmetry down
the length (c-axis) ofthe virus andis the origin ofthe ordering
offusion peptides in a three-dimensionalstructure (FIG. 1B).
Computational analysis of peptide expression on the capsid
of the virus revealed that the nearest neighbor peptide sepa-
ration stabilized around 3 nm at and above 20% incorporation
(FIG. 1C). Consequently, high incorporation of the substrate
specific fusion peptides is not required for complete miner-
alization ofthe virus to occur. Tri-functional templates can be
realized through further genetic modification ofthe proximal
and remote tips of the virus (specifically the gP3 and gP9
proteins, 22) which can be usedto push the current system to
higher aspect ratios and introduce materials including mate-
rials such as, for example, noble metals, semiconductors, and
oxides to assemble functional heterostructured materials
(FIG. 1D).
Mineralization of Scaffolds
Mineralization of the ZnS and CdS systems have been
described previously (11, 12; 17) and involves incubation of
the viral template with metal salt precursors at reduced tem-
peratures to promote uniform orientation of the nanocrystals
during nucleation (23), leading to the preferred crystallo-
graphic orientation of nucleated nanocrystals with respect to
the long axisofthe virus. Prior to annealing, wurtzite ZnS and
CdS nanocrystals (3-5 nm) grown on thevirus surface were in
close contact and preferentially oriented with the [001] direc-
tion and the (100) plane perpendicular to the wire length
direction, which is supported by Electron Diffraction (ED),
High Resolution Transmission Electron Microscopy (HR-
TEM), High Angle Annular Dark Field Scanning Transmis-
sion Electron Microscopy (HAADF-STEM), and Dark-field
Diffraction-contrast Imaging (FIG.2) (24). Particles attached
to the virus were likely prohibited from fusing under initial
synthesis conditions likely due for example to the blocking
effects of the neighboring peptides, and therefore removal of
the template was desired in order to form single crystal
nanowires. Thermal analysis of the virus-particle system
showed complete removalofthe organic materials by 350° C.
(25), which corresponded to the minimum temperature
observed for the fusion of adjacent particles by TEM with
annealing performedin situ using a thermal stage (26).
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Formation of Nanowires
Annealing of the mineralized viruses at temperatures
below the ZnS and CdS particle melting point (400-500° C.)
allowed the polycrystalline assemblies to form single crystal
nanowires (for ZnS nanowires, length distribution was about
600-650 nm; for CdS nanowires, length distribution was
about 475-500 nm;the diameters for ZnS and CdS nanowires
were about 20 nm) through removalof the organic template
and minimizationofthe interfacial energy (27) (FIG. 2B, E).
ED and HRTEMrevealed the single crystal nature of indi-
vidual nanowiresthat inherited the preferred orientation seen
in the precursor polycrystalline wires through removalofthe
grain boundaries (28, 29) (FIGS. 2C and D). The [100] direc-
tion and (001) plane orientations ofthe observed ZnS nanow-
ires where consistent with common elongation directions for
II-VI nanowires, even though these are thermodynamically
high energy planes (FIGS. 2B and C; 14, 30, 31). HRTEM of
the single crystal CdS nanowires revealed a lattice spacing of
2.4 A that was consistent with the unique 2.4519 A separation
between two (102) planes in bulk wurtzite CdS crystals
(JCPDS #41-1049). The 43.1° orientation of (102) lattice
planes with respect to the nanowire axis indicated that the
nanowire was elongated along the [001] direction and again
confirmed the wurtzite structure (FIG. 2F).
Formation of Ferromagnetic Nanowires
Extendingthe virus-directed synthesis approach tothefer-
romagnetic L1, CoPt and FePt systems was carried out for
demonstrating both the diversity of applicable materials and
to address current technological issues regarding the devel-
opment of low-dimensional magnetic materials. Platinum
alloyed magnetic materials of the chemically ordered L1,
phase have been ofrecent interest due to their high coercivity,
resistance to oxidation, and inherent magnetic anisotropy
important for ultrahigh density recording media (32).
Although synthetic routes such as VLS yield exquisite 1-D
semiconducting structures and non-specific template
schemes are applicable to a range of materials, both have
faced difficulties in producing high-quality, crystalline metal-
lic and magnetic nanowires in free standing form (33).
Genetically Engineered Scaffolds
The M13 bacteriophage was modified by fusing either the
CP7 CoPtspecific or FP12 FePt specific peptide into the virus
capsid. Nucleation of the CoPt and FePt particles was
achieved via the chemical reduction of metal precursorsalts
in the presence ofgP8 modified viruses (18, 34). Annealing of
the assemblies at 350° C. promoted the growth of crystalline
CoPt and FePt nanowires of the L1, phase that were uniform
in diameter (10 nm+/-5%). The crystalline nature ofthe wires
can be seen in the selected area ED pattern, which also shows
the characteristic (001) and (110) L1, peaks, and by high
resolution TEMlattice imaging (FIG. 3C, D). The (111) plane
perpendicular to the long axis ofthe CoPt wires with a lattice
spacing of 2.177 A wasin agreementwith the reported value
of 2.176 A, and again confirmedthe highly crystalline nature
ofthe material (FIG. 3D, JCPDS #43-1358). The persistence
of the L1, phase, which is kinetically accessible above 550°
C. (15), was attributed to the propensity of particles to main-
tain their orientation during aggregation-based annealing.
Nanowire Design Simulations
The invention including the working examples can be fur-
ther understood with use ofsimulation methods. For example,
Monte Carlo simulations of the A7 constrained sequence
resulted in a 21% decreasein the standard deviation ofback-
bonedihedral angles upon transfer of the peptide from isola-
tion into the capsid environment, demonstrating the rigidity
imposedonthe fusion peptide (35). Ordering ofthe nucleated
particles with regards to preferred crystallographic orienta-
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tion along the length ofthe virus wasbelieved to be a result of
the stability of the peptide fusion and the symmetry of the
virus coat. This nanocrystal ordering promoted the single
crystal nature of the annealed nanowires by satisfying the
orientation requirements of the aggregation-based crystal
growth mechanism (14). Although particles exhibiting orien-
tations not coherent with that of the majority were to be
expected, these minority nanocrystals should rotate to adopt
the preferred crystallographic orientation and merge with the
majority to minimize both the interfacial and grain boundary
energies (31, 36, 37).
Additional experimental details can be foundin several of
the below footnotes.
Although making and using various embodiments of the
present invention are discussed in herein, it will be appreci-
ated that the present invention provides many applicable
inventive concepts that can be embodiedin a wide variety of
specific contexts. The specific embodiments discussed herein
are merelyillustrative of specific ways to make and use the
invention, and do not delimit the scope of the invention.
The following references are not admitted priorart but can
be used to guide one skilled in the art in the practice of the
present invention, and also are incorporated herein by refer-
ence in their entirety.
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The invention claimedis:
1. An inorganic nanowire composition, comprising a plu-
rality of inorganic nanowires, each inorganic nanowire com-
prising a plurality of fused inorganic nanoparticles, orienta-
tion and position of the fused inorganic nanoparticles being
definedby a location ofbinding ofthe inorganic nanoparticles
to an organic template.
2. The inorganic nanowire composition ofclaim 1, wherein
alength ofthe inorganic nanowires1s definedby a length ofan
organic template.
3. The inorganic nanowire composition ofclaim 1, wherein
the plurality of inorganic nanoparticles comprises the same
composition.
4. The inorganic nanowire composition ofclaim 1, wherein
the plurality of inorganic nanoparticles comprises different
compositions.
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5. The inorganic nanowire composition ofclaim 4, wherein
the nanowires of different compositions are fused along a
length of the nanowire in a periodic pattern.
6. The inorganic nanowire composition ofclaim 1, wherein
the plurality of inorganic nanoparticles comprises one or
more ofa semiconductor material, a metallic material, a metal
oxide material, a magnetic material, or mixtures thereof.
7. The inorganic nanowire composition ofclaim 1, wherein
the plurality ofnanowires has a length of from about 250 nm
to about 5 microns and a width offrom about 5 nm to about 50
nm.
8. The inorganic nanowire composition ofclaim 1, wherein
the plurality ofinorganic nanowires comprises a substantially
monodisperse average length.
9. The inorganic nanowire composition ofclaim 1, wherein
the inorganic nanowires comprises a substantially monodis-
perse average width.
